Morpholino

MO2-pdcd2

ID
ZDB-MRPHLNO-140106-3
Name
MO2-pdcd2
Previous Names
  • 5ssMO (1)
Target
Sequence
5' - TAACATCTGTTTTGCATCACCTGGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-pdcd2
Phenotype
Phenotype resulting from MO2-pdcd2
Phenotype Fish Figures
apoptotic process increased occurrence, abnormal WT + MO2-pdcd2 Fig. 6Fig. 7 from Kramer et al., 2013
axis decreased length, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
blood vessel has fewer parts of type blood cell, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
blood vessel blood lacks parts or has fewer parts of type nucleate erythrocyte, abnormal sd2Tg + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
brain necrotic, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
caudal fin curled, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
caudal fin increased thickness, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
caudal vein plexus malformed, abnormal y1Tg + MO2-pdcd2 Fig. 3 from Kramer et al., 2013
dorsal longitudinal anastomotic vessel broken, abnormal y1Tg + MO2-pdcd2 Fig. 3 from Kramer et al., 2013
dorsal longitudinal anastomotic vessel malformed, abnormal y1Tg + MO2-pdcd2 Fig. 3 from Kramer et al., 2013
erythroblast increased amount, abnormal sd2Tg + MO2-pdcd2 Fig. 4 from Kramer et al., 2013
erythroblast increased size, abnormal sd2Tg + MO2-pdcd2 Fig. 4 from Kramer et al., 2013
erythroblast nucleus increased size, abnormal sd2Tg + MO2-pdcd2 Fig. 4 from Kramer et al., 2013
erythrocyte differentiation arrested, abnormal sd2Tg + MO2-pdcd2 Fig. 4 from Kramer et al., 2013
eye decreased size, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
hematopoietic stem cell absent, abnormal WT + MO2-pdcd2 Fig. 5 from Kramer et al., 2013
hematopoietic system cell accumulation ball anterior region, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
mitotic cell cycle process quality, abnormal WT + MO2-pdcd2 Fig. 6 from Kramer et al., 2013
mitotic spindle assembly process quality, abnormal WT + MO2-pdcd2 Fig. 6 from Kramer et al., 2013
nucleate erythrocyte accumulation intermediate cell mass of mesoderm, abnormal sd2Tg + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
nucleate erythrocyte accumulation common cardinal vein, abnormal sd2Tg + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
nucleate erythrocyte immature, abnormal sd2Tg + MO2-pdcd2 Fig. 4 from Kramer et al., 2013
somite deformed, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
ventricular system dilated, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
whole organism circulating cell lacks parts or has fewer parts of type blood cell, abnormal WT + MO2-pdcd2 Fig. 2 from Kramer et al., 2013
Phenotype of all Fish created by or utilizing MO2-pdcd2
Phenotype Fish Conditions Figures
brain necrotic, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
whole organism circulating cell lacks parts or has fewer parts of type blood cell, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
somite deformed, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
mitotic cell cycle process quality, abnormal WT + MO2-pdcd2 standard conditions Fig. 6 from Kramer et al., 2013
apoptotic process increased occurrence, abnormal WT + MO2-pdcd2 standard conditions Fig. 6Fig. 7 from Kramer et al., 2013
eye decreased size, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
hematopoietic system cell accumulation ball anterior region, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
hematopoietic stem cell absent, abnormal WT + MO2-pdcd2 standard conditions Fig. 5 from Kramer et al., 2013
axis decreased length, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
mitotic spindle assembly process quality, abnormal WT + MO2-pdcd2 standard conditions Fig. 6 from Kramer et al., 2013
ventricular system dilated, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
blood vessel has fewer parts of type blood cell, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
caudal fin curled, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
caudal fin increased thickness, abnormal WT + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
nucleate erythrocyte accumulation common cardinal vein, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
erythroblast nucleus increased size, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 4 from Kramer et al., 2013
nucleate erythrocyte accumulation intermediate cell mass of mesoderm, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
erythroblast increased size, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 4 from Kramer et al., 2013
blood vessel blood lacks parts or has fewer parts of type nucleate erythrocyte, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 2 from Kramer et al., 2013
nucleate erythrocyte immature, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 4 from Kramer et al., 2013
erythroblast increased amount, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 4 from Kramer et al., 2013
erythrocyte differentiation arrested, abnormal sd2Tg + MO2-pdcd2 standard conditions Fig. 4 from Kramer et al., 2013
dorsal longitudinal anastomotic vessel broken, abnormal y1Tg + MO2-pdcd2 standard conditions Fig. 3 from Kramer et al., 2013
caudal vein plexus malformed, abnormal y1Tg + MO2-pdcd2 standard conditions Fig. 3 from Kramer et al., 2013
dorsal longitudinal anastomotic vessel malformed, abnormal y1Tg + MO2-pdcd2 standard conditions Fig. 3 from Kramer et al., 2013
Citations